India To Use GeneXpert TB Test To Improve Diagnosis Among Children

Devex: India rolls out new TB diagnosis aimed at catching child cases
“…India will soon roll out a national program aimed at speedily spotting cases of TB and drug resistance in all suspected cases. TB has often gone untreated in children because it has also gone undetected. But if children get the drugs they need, the outcomes are often better than those of adult patients. India’s Universal Drug Sensitivity Test, which begins this September, will exploit a relatively new technology called GeneXpert, a molecular diagnostic test for the early diagnosis of TB…” (Cousins, 9/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.